MEDERA'S SARDOCOR ANNOUNCES FDA CLEARANCE OF IND FOR FIRST-IN-HUMAN GENE THERAPY CLINICAL TRIAL FOR DMD CARDIOMYOPATHY - Brazil Business Today
• With modern therapeutic strategies to prolong life expectancy, an increasing number of Duchenne Muscular Dystrophy (DMD) patients survive to develop
Source: einnews.com